Worldwide Markets for PCR in Screening and Diagnostics to Surpass USD 27 Billion Mark by 2015, Expects Biopharm Reports
06 Jun 2013 • by Natalie Aster
PCR is used in a wide variety of molecular biology applications, including sequencing, genetic fingerprinting, cloning, disease research, diagnostics, drug discovery, disease biomarkers and forensics. According to the report “PCR in Screening and Diagnostics: Market Developments, Growth Areas and Opportunities” by Biopharm Reports, today this technique continues to grow and some estimates suggest that by 2015 global markets for this technique will exceed $27 billion.
PCR in Screening and Diagnostics: Market Developments, Growth Areas and Opportunities
Published: June, 2013
Price: US$ 2,794.00
Biopharm Reports has carried out a market study of the use of PCR in screening and diagnostics, involving the participation of 173 end-users and decision-makers in more than 50 countries. This study was carried out to investigate market developments, and to identify new insights and opportunities to developers and vendors in this field.
This study focused in particular on current and future techniques and applications, end-users’ plans for using PCR in screening and diagnostics over the next three years, as well as preferred products, purchasing and new developments. Other market areas included new and emerging applications, end-users’ principal PCR systems and their strengths and weaknesses, current and future budgets, budget breakdown, cost per sample, consumables, innovation, software and sample preparation.
More information can be found in the report “PCR in Screening and Diagnostics: Market Developments, Growth Areas and Opportunities” by Biopharm Reports.
To order the report or ask for sample pages contact [email protected]